Convergene
Cambridge
Maryland
United States
About Convergene
ConverGene is a small molecule discovery company leveraging rational drug design. Our mission is to develop therapeutics with novel mechanisms of action for cancer patients with limited or no treatment options.YEAR FOUNDED:
2010
LEADERSHIP:
CEO: Jeff Strove
3 articles about Convergene
-
Convergene Announces Sponsored Research Agreement With MD Anderson Cancer Center
9/18/2017
-
Convergene Release: Company Announces Sponsored Research Agreement With University of Maryland, Baltimore To Evaluate First-In-Class Anti-Cancer Agents
1/26/2017
-
Convergene Announces A License Agreement With The National Center For Advancing Translational Sciences
12/14/2016